103 related articles for article (PubMed ID: 10794812)
21. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa.
Tough IR; Holliday ND; Cox HM
J Pharmacol Exp Ther; 2006 Oct; 319(1):20-30. PubMed ID: 16807358
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y1 and Y2 receptors.
Schober DA; Gackenheimer SL; Gehlert DR
Eur J Pharmacol; 1996 Dec; 318(2-3):307-13. PubMed ID: 9016919
[TBL] [Abstract][Full Text] [Related]
24. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
[TBL] [Abstract][Full Text] [Related]
25. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Gehlert DR; Schober DA; Morin M; Berglund MM
Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
[TBL] [Abstract][Full Text] [Related]
26. Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
Bergdahl A; Nilsson T; Sun XY; Hedner T; Edvinsson L
Eur J Pharmacol; 1998 Nov; 360(2-3):165-73. PubMed ID: 9851583
[TBL] [Abstract][Full Text] [Related]
27. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Odagaki Y; Nishi N; Nakagawa S; Koyama T
J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
[TBL] [Abstract][Full Text] [Related]
28. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
30. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction.
Berglund MM; Schober DA; Statnick MA; McDonald PH; Gehlert DR
J Pharmacol Exp Ther; 2003 Jul; 306(1):147-56. PubMed ID: 12665544
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
Krause J; Eva C; Seeburg PH; Sprengel R
Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
Goumain M; Voisin T; Lorinet AM; Balasubramaniam A; Laburthe M
Eur J Pharmacol; 1998 Dec; 362(2-3):245-9. PubMed ID: 9874177
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
[TBL] [Abstract][Full Text] [Related]
35. A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.
Potter EK; Barden JA; McCloskey MJ; Selbie LA; Tseng A; Herzog H; Shine J
Eur J Pharmacol; 1994 May; 267(3):253-62. PubMed ID: 8088364
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors.
Sharma P; Arvidsson AK; Wraith A; Beck-Sickinger AG; Jönsson-Rylander AC; Larhammar D
Gen Comp Endocrinol; 1999 Sep; 115(3):422-8. PubMed ID: 10480994
[TBL] [Abstract][Full Text] [Related]
38. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
Voisin T; Goumain M; Lorinet AM; Maoret JJ; Laburthe M
J Pharmacol Exp Ther; 2000 Feb; 292(2):638-46. PubMed ID: 10640301
[TBL] [Abstract][Full Text] [Related]
39. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
40. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
